Overview of health risk communication strategies in the context of COVID-19 vaccination in India

Authors

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20220268

Keywords:

Communication strategies, COVID-19 vaccination, Health risk

Abstract

Vaccines are being considered as the most promising approach to curb the COVID-19 pandemic. Drug Controller General of India (DCGI) authorized restricted emergency use of two vaccines, Covishield and Covaxin on 3rd January 2021. The vaccination drive in India was launched on 16th January 2021. Conducting vaccination at this scale in a country like India is a daunting task because of inherent demographical challenges comprising different ages, incomes, and linguistic profiles of people. An effective health risk communication (HRC) strategy is highly important to reach out to the masses and make them realize the importance of vaccination. It is a crucial pillar for developing national core capacity during emerging infectious diseases. Studying the five months post vaccine rollout in India and assessing the communication strategies based on the principles of HRC is going to provide us good insights into how India has fared in this context. Efforts for COVID-19 vaccination have reached a crucial juncture with the roll-out of vaccination for the largest age group of 18-44 years since 1st May 2021. Transparent, clean and precise answers about facts are either known or unknown, need to be maintained. Vaccine-related myths and higher reporting of deaths due to unknown causes must be stopped. The media must proof check all vaccine-related news with relevant and confirmed scientific materials only and present it with the necessary disclosures. This review focussed on an overview of health risk communication strategies in the context of COVID-19 vaccination in India. 

Author Biographies

Anuradha Kunal Shah, Department of Community Medicine, Seth GS Medical College and KEM Hospital, Mumbai, Maharashtra, India

Assistant Professor, Department of Community Medicine, Seth GSMC and KEMH

Swarnika Pal, Department of Community Medicine, Seth GS Medical College and KEM Hospital, Mumbai, Maharashtra, India

Assistant Professor, Department of Community Medicine, Seth GSMC and KEMH

References

Andre FE, Booy R, Bock HL, Clemens J, Datta SK, John TJ, et al. Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ. 2008;86(2):140-6.

World Health Organisation (WHO). Emergencies preparedness, response safety of pandemic vaccines. 2009;(August):3-5

Kamradt-Scott A. The International Health Regulations (2005): Strengthening Their Effective Implementation and Utilisation. Int Organ Law Rev. 2019;16(2):242-71.

Singh P, Dhawan V, Rishi G. COVID-19 vaccine communication strategy. New Delhi; 2021. Available at: https://www.mohfw.gov.in/pdf/ Covid19CommunicationStrategy2020.pdf. Accessed on 21 May 2021.

National Risk Communication Plan. New Delhi; 2016. Available at: https://ncdc.gov.in/WriteReadData/l892s/File593.pdf. Accessed on 21 May 2021.

Sarojini N, Deepa V. Trials and tribulations: an expose of the HPV vaccine trials by the 72nd Parliamentary Standing Committee Report. Indian J Med Ethics. 2013;10:220-2.

Communication for polio eradication and routine immunization Checklists and easy reference guides WHO, UNICEF, USAID (Basic II and Change projects). 2002 Available at: https://www.who.int/ biologicals/publications/meetings/areas/vaccines/polio/PolioCommsChklsts.pdf?ua=1. Accessed on 11 June 2021.

COVID-19 vaccine communication strategy released - Express Healthcare. Available at: https://www.expresshealthcare.in/news/covid-19-vaccine-communication-strategy-released-health-ministry/426676/. Accessed on 11 June 2021.

Prime Minister reviews status of COVID-19 and preparedness for COVID-19 vaccination [Internet]. Ministry of Health and Family Welfare. 2021 Available at: https://pib.gov.in/PressReleasePage. aspx?PRID=1687305. Accessed on July 5, 2021.

Chat on WhatsApp with MyGov Corona Helpdesk. Available at: https://api.whatsapp.com/send/ ?phone=919013151515&text=Hi&app_absent=0. Accessed on 21 May 2021.

India Fights Corona (@COVID News By MIB)/Twitter. Available at: https://twitter.com/ COVIDNewsByMIB. Accessed on 21 May 2021.

Dr. Harsh Vardhan on Twitter: "There is no scientific evidence to suggest that #COVIDVaccine could cause infertility in either men or women. Kindly do not pay heed to such rumours or information from unverified sources. #Stay Informed Stay Safe @PMO India @MoH. Available at: https://twitter.com/drharshvardhan/status/ 1349687664639762435?s=20. Accessed on 14 June 2021.

Survey Shows Rising Vaccine Hesitancy Threatening COVID-19 Recovery. Press releases. World Economic Forum. Available at: https://www.weforum.org/press/2020/11/survey-shows-rising-vaccine-hesitancy-threatening-covid-19-recovery/. Accessed on 21 May 2021.

Rzymski P, Zeyland J, Poniedziałek B, Małecka I, Wysocki J. The perception and attitudes toward COVID-19 vaccines : a cross-sectional study in Poland. Vaccines. 2021;9:7-13.

Sircar S. We need to identify and eliminate vaccine hesitancy among healthcare workers. Available at: https://science.thewire.in/health/healthcare-workers-vaccine-hesitancy/. Accessed on 20 April 2021.

Healthcare workers declining COVID-19 vaccine is a matter of sadness: Government. Available at: https://www.businesstoday.in/latest/trends/healthcare-workers-declining-covid-19-vaccine-is-a-matter-of-sadness-govt/story/428431.html. Accessed on 20 April 2021.

COVID-19 vaccine: 74% scheduled health workers didn’t get second shot out of every eligible, both the doses are taken. Available at: https://www. downtoearth.org.in/news/health/covid-19-vaccine-74-scheduled-health-workers-didn-t-get-second-shot-75570#:~:text=Three. Accessed on 20 April 2021.

Viswanath K, Rn H, Singh Basra S, Chourey N. Corona virus disease 2019 vaccination drive: the perceptions and acceptance of vaccination among health care workers. Asian J Pharm Clin Res. 2021;14:20-1.

Singhania N, Kathiravan S, Pannu AK. Acceptance of coronavirus disease 2019 vaccine among health-care personnel in India: a cross-sectional survey during the initial phase of vaccination. Clin Microbiol Infect. 2021;9:23-7.

Press Statement by the Drugs Controller General of India (DCGI) on Restricted Emergency approval of COVID-19 virus vaccine. Available at: https://pib.gov.in/PressReleseDetail.aspx?PRID=1685761. Accessed on 29 June 2021.

Ella R, Reddy S, Blackwelder W, Potdar V, Yadav P. Efficacy, safety and lot to lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): a double-blind, randomised, controlled phase 3 trial. medRxiv Prepr. 2021;27-35.

The National Regulator grants Permission for Restricted Use in Emergency Situations to Sputnik-V vaccine. Available at: https://pib.gov.in/Press ReleasePage.aspx?PRID=1711342. Accessed on 29 June 2021.

PM addresses the Nation. Available at: https://pib.gov.in/PressReleasePage.aspx?PRID=1725113. Accessed on 29 June 2021.

Govt. is committed to transparency in COVID vaccination programme: Health Ministry. Available at: https://www.livemint.com/politics/policy/govt-is-committed-to-transparency-in-covid-vaccination-programme-health-ministy-11623315428048.html. Accessed on 29 June 2021.

India’s vaccine policy requires transparency - Hindustan Times. Available at: https://www. hindustantimes.com/opinion/indias-vaccine-policy-requires-transparency-101622297613150.html. Accessed on 29 June 2021.

Fadnavis faces flak as 22-year-old nephew Tanmay gets COVID-19 vaccine. Deccan Herald. Available at: https://www.deccanherald.com/national/west/ fadnavis-faces-flak-as-22-year-old-nephew-tanmay-gets-covid-19-vaccine-976427.html Accessed on 5 July 2021.

Cohen AF, van Gerven J, Burgos JG, de Boer A, Foucher RAM, Flore H, et al. COVID-19 vaccines: the importance of transparency and fact-based education. Br J Clin Pharmacol. 2020;86(11):2107-10.

We Need More Transparency in COVID-19 Vaccine Development. Time. Available at: https://time.com/ 5890216/transparency-covid-vaccine-development/. Accessed on 29 June 2021.

Managing the COVID-19 infodemic: promoting healthy behaviours and mitigating the harm from misinformation and disinformation. Available at: https://www.who.int/news/item/23-09-2020-managing-the-covid-19-infodemic-promoting-healthy-behaviours-and-mitigating-the-harm-from-misinformation-and-disinformation. Accessed on 29 June 2021.

India Covid-19: Misleading claims shared about vaccines- BBC News. Available at: https://www.bbc.com/news/55768656 Accessed on 14 June 2021.

COVID-19 vaccines 110% safe, impotency rumours complete nonsense: DCGI. India News- Times of India. Available at: https://timesofindia.indiatimes. com/india/covid-19-vaccines-110-safe-impotency-rumours-complete-nonsense-dcgi/articleshow/8008 2000.cms Accessed on 14 June 2021.

Myths & Facts on India’s Vaccination Process. PIB. NITI Aayog. 2021. Available at: https://pib.gov.in/PressReleasePage.aspx?PRID=1722078. Accessed on 11 June 2021.

Coronavirus vaccine will be a way of injecting people with microchips? Don’t fall for this Facebook hoax- Times of India. Available at: https://timesofindia.indiatimes.com/life-style/health-fitness/health-news/coronavirus-vaccine-will-be-a-way-of-injecting-people-with-microchips-dont-fall-for-this-facebook-hoax/articleshow/78404956.cms. Accessed on 14 June 2021.

Krishna Ella on Poonawalla’s ‘Safe, Like Water’ Remark on Vaccine. Available at: https://www. thequint.com/news/india/krishna-ella-on-adar-poonawalla-safe-like-water-remark-on-vaccine#read-more. Accessed on 21 May 2021.

Vaccine firms Bharat Biotech, Serum Institute patch up after war of words. Business Standard News. 2021. Available at: https://www.business-standard.com/article/current-affairs/vaccine-firms-bharat-biotech-serum-institute-patch-up-after-war-of-words-121010500995_1.html. Accessed on 11 June 2021.

Downloads

Published

2022-01-28

How to Cite

Shah, A. K., & Pal, S. (2022). Overview of health risk communication strategies in the context of COVID-19 vaccination in India. International Journal Of Community Medicine And Public Health, 9(2), 1091–1096. https://doi.org/10.18203/2394-6040.ijcmph20220268

Issue

Section

Review Articles